search
Back to results

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

Primary Purpose

Inflammation, Cancer, Autoimmune Diseases

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Ashwagandha
Sponsored by
National University of Natural Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Inflammation focused on measuring stress, inflammation, natural remedy, cytokines, interleukin, inflammatory conditions, auto-immune disorders

Eligibility Criteria

18 Years - 55 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy adults, not pregnant

Exclusion Criteria:

  • Fear or aversion to needles or blood draws.
  • Recent infection or immunocompromised.
  • Allergy to cow's milk.
  • Known herb allergies.
  • Aversions or medical contraindications to alcohol.
  • Medication contra-indications, such as: benzodiazepines, CNS depressants,immunosuppressants and thyroid hormone and supplements.

Sites / Locations

  • Helfgott Research Institute

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

1

Arm Description

Receives Ashwagandha herb.

Outcomes

Primary Outcome Measures

The primary endpoint of this study will be to measure immune cell activation, inflammatory cytokines and cortisol levels after administration of the herb.

Secondary Outcome Measures

The secondary endpoint of this study will be to measure and correlate stress levels to the use of the herb.

Full Information

First Posted
January 2, 2009
Last Updated
March 17, 2010
Sponsor
National University of Natural Medicine
Collaborators
Helfgott Research Institute
search

1. Study Identification

Unique Protocol Identification Number
NCT00817752
Brief Title
Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation
Official Title
Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation
Study Type
Interventional

2. Study Status

Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
January 2008 (Actual)
Study Completion Date
February 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
National University of Natural Medicine
Collaborators
Helfgott Research Institute

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Ayurvedic medicine has been practiced in for more than 2,500 years. Ashwagandha is one of the most widely utilized herbs in the system. It is thought to affect the endocrine, immune, nervous, and cardiopulmonary systems. This study is designed as a preliminary investigation of the effects of Ashwagandha on stress, inflammation, and immune modulation. Participants will take the liquid extract in cow's milk twice a day for five days. The results of initial, one-day, and final blood draws will be compared to determine participant's beginning and ending levels of cortisol, inflammatory cytokines, and immune-cell activation (CD4 T-cells, CD8 T-cells, B cells and natural killer cells). Measurements will be completed using flow cytometry and ELISA assay. The purpose of this study is to determine which effects of Ashwagandha are most suitable for further investigation.
Detailed Description
Due to the increased use of alternative medicine, supplements and herbs are consumed more frequently in the treatment of common ailments. This pilot study investigates the immune, anti-inflammatory and anti-stress effects of Ashwagandha in human subjects. Liquid extract of the herb will be taken followed by milk; this mode of administration will be used as it approximates the traditional administration as well as making self administration easier for participants. Extract will be taken in 3 milliliter quantities 2 times per day, (morning and evening), for five days. Total dosage of 6 milliliters will approximate the higher end of the traditional daily dosage of 6 grams daily of powdered root. Flow of visit: 25 participants will arrive at the research lab and after being consented, filling out health histories and two stress questionnaires, (POMS and STAI Self-Evaluation), average milk intake questionnaire. The 25 participants will receive blood draws. They will then be administered the herb extract, milk and instructions for taking them. Subjects will return to the research institute after 24 hours for a second blood draw and then after 5 days for a final blood draw and two more stress questionnaires, (POMS and STAI Self-Evaluation). Once the blood samples are drawn, they will be refrigerated and processed within 24 hours at the NCNM laboratory. Initially they will be centrifuged to separate the white from the red blood cells using Ficoll separating tubes. Then the white blood cells will be stained using CD69 marker (Cytokine Detection type 69) which assesses cell-surface phenotypic markers in combination with intracellular cytokines, measuring response to activation. It is especially effective for rare-event, antigen-specific events, such as the administration of a specific immune-stimulating herbal tincture. We will also stain with other similar florescent CD markers specific for CD4 T-cells, CD8 T-cells, B-cells, NK cells, and macrophages. These markers will be analyzed using a FACScan flow cytometer, which will count the number of cells that have been activated in each subtype of the immune cell and overall action. Blood will also be analyzed for cortisol levels and inflammatory cytokines, (IL-1, IL-6 and TNF-alpha) using the ELISA assay procedure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Inflammation, Cancer, Autoimmune Diseases
Keywords
stress, inflammation, natural remedy, cytokines, interleukin, inflammatory conditions, auto-immune disorders

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Description
Receives Ashwagandha herb.
Intervention Type
Dietary Supplement
Intervention Name(s)
Ashwagandha
Intervention Description
Participants consume 3mL of Ashwagandha for 5 days. Blood work/immune cells (CD4 T-cells, CD8 T-cells, B-cells, NK cells, macrophages, IL-1, IL-6 and TNF-alpha) and psychological assessments (POMS and STAI Self-Evaluation) given at specified time intervals.
Primary Outcome Measure Information:
Title
The primary endpoint of this study will be to measure immune cell activation, inflammatory cytokines and cortisol levels after administration of the herb.
Time Frame
24 hours and again at 5 days
Secondary Outcome Measure Information:
Title
The secondary endpoint of this study will be to measure and correlate stress levels to the use of the herb.
Time Frame
24 hours and again at 5 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy adults, not pregnant Exclusion Criteria: Fear or aversion to needles or blood draws. Recent infection or immunocompromised. Allergy to cow's milk. Known herb allergies. Aversions or medical contraindications to alcohol. Medication contra-indications, such as: benzodiazepines, CNS depressants,immunosuppressants and thyroid hormone and supplements.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Heather Zwickey, PhD
Organizational Affiliation
Helfgott Research Institute at NCNM
Official's Role
Principal Investigator
Facility Information:
Facility Name
Helfgott Research Institute
City
Portland
State/Province
Oregon
ZIP/Postal Code
97201
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

We'll reach out to this number within 24 hrs